Roche CEO Thomas Schinecker joins Bloomberg's "The Opening Trade" to discuss his company's earnings and the timeline for the potential launch for Roche's blockbuster breast cancer pill that may become one of the company's biggest sellers by the end of the year.

Dan Ives Talks Micron Earnings
08:49

Siemens CEO Roland Busch Talks AI
07:15

Former SEC Chair Gary Gensler Talks AI Hype, IPO Outlook
13:20